argenx SE reported $245.36M in Net Income for its fiscal quarter ending in June of 2025.


Net Income Change Date
AstraZeneca USD 2.45B 466M Jun/2025
Galapagos EUR -105748000 47.66M Jun/2025
Genmab DKK 336M 141M Jun/2025
GlaxoSmithKline GBP 1.44B 181M Jun/2025
GRIFOLS EUR 117.06M 57.34M Jun/2025
Hikma Pharmaceutical USD 133M 93M Dec/2024
Qiagen NV USD 96.25M 5.49M Jun/2025
UCB EUR 857M 649M Dec/2024